WeVote
Log In

Bill

Bill

A 9012

Prohibits non-physicians from having control of professional corporations organized to practice medicine

2025 Regular Session Introduced by Anna Kelles

Prohibits non-physicians from controlling professional corporations that practice medicine, preserving physician-led governance and decision-making in medical groups.

REFERRED TO CORPORATIONS, AUTHORITIES AND COMMISSIONS
0
WeVote Research Nonpartisan
Bill Summary · A 9012

Summary: Assembly Bill A 9012 — Prohibits Non-Physicians from Having Control of Professional Corporations Organized to Practice Medicine

Overview

  • Bill number: A 9012
  • Title: Prohibits non-physicians from having control of professional corporations organized to practice medicine
  • Sponsor: Assemblymember Anna Kelles (primary)
  • Introduced: August 13, 2025
  • Status: Referred to the Committee on Corporations, Authorities and Commissions
  • Related legislation: Senate companion S 8442

Purpose and Intent

The bill seeks to ensure that professional corporations organized to practice medicine remain under physician control. This aligns with longstanding concerns about the corporate practice of medicine, which generally restricts non-physician ownership or control of medical practice decisions. The core aim is to preserve physician professional autonomy in clinical decision-making and governance within physician-led corporate structures.

Key Provisions (as Available)

  • Core prohibition: Non-physicians would be prohibited from having control of professional corporations organized to practice medicine.
  • Definitions and scope: The full text would define terms such as “professional corporation,” “control,” and who qualifies as a physician for purposes of the prohibition.
  • Implementation details: The bill would likely specify how control is determined (e.g., ownership, voting rights, board composition) and potential enforcement mechanisms and penalties. However, those specific details are not provided in the information available here.

Who Would Be Affected

  • Affected entities: Professional corporations organized to practice medicine in New York.
  • Affected individuals: Non-physician owners, investors, or partners who would be unable to exercise control under the new rules.
  • Indirect effects: Physicians and medical groups that rely on corporate structures for practice management, as well as patients who receive care from these physician-led entities.

Procedural and Timeline Aspects

  • Committee action: Referred to the Assembly Committee on Corporations, Authorities and Commissions (procedure noted twice in the record).
  • Next steps: The bill would move through committee consideration, potential amendments, and, if advanced, floor votes in the Assembly. If it passes, it would proceed to the Senate (with its companion S 8442) and then to negotiation for any differences before final passage and potential enactment.

Related Legislation

  • Senate companion: S 8442 (listed as the companion bill; note appears twice in the record). This indicates parallel consideration in the Senate and the potential for eventual conference with any Assembly version.

Potential Impacts and Considerations

  • Policy impact: Strengthens physician control over medical practice ownership and governance, reinforcing the traditional doctrine prohibiting the corporate practice of medicine.
  • Economic and market impact: Could affect investment structures, ownership arrangements, and the formation of physician groups. May influence mergers, acquisitions, or formations of new practices.
  • Operational considerations: Practices may need to adjust governance documents, ownership stakes, and voting arrangements to ensure compliance if the bill advances.

Next Steps for Readers

  • Monitor legislative progress through the Assembly’s Committee on Corporations, Authorities and Commissions.
  • Review the full bill text when available for precise definitions, thresholds, enforcement provisions, and any transitional rules.
  • Check for the Senate companion’s status (S 8442) to gauge crossover progress and potential conference updates.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.